Pericles (Perry) Calias, PhD

Dr. Calias has over 25 years of biopharma industry experience with a strong track record in compound development and pipeline progression, as well as building research and development organizations. Previously he was Chief Operations and Development Officer at Revolo Biotherapeutics, Chief Scientific Officer at Cerecor, and Chief Vice President of Global CMC and Product Development at Sucampo. Earlier in his career he held a variety of research and development positions both in clinical and non-clinical roles of expanded leadership at Shire HGT and Genzyme. He obtained his Ph.D. in bio-organic Chemistry from Tufts University and his B.S. in biology from Suffolk University.